Journal of Surgical Oncology · 1991 · 26 citations · 17 references
MedicineOncologySurgeryChemotherapyGastrointestinal OncologyOncologic SurgeryCytoreductive SurgeryLiver CancerHepatic Arterial Infusion ChemotherapyMultimodality Treatment IntegrationPrimary Liver CancerPrimary Liver TumorsSurgical Cytoreduction
For decades, unresectable primary liver cancer (PLC) determined by operation was incurable. However, a retrospective study of 24 years' materials with unresectable PLC indicated that 5-year survival of unresectable PLC has increased from 0% in 1966-1977 (n = 137) to 16.9% in 1978-1989 (n = 345). This encouraging improvement was mainly a result of cytoreduction therapy followed by sequential resection. Multimodality combination treatment with hepatic artery ligation, plus hepatic artery infusion with chemotherapy, plus radioimmunotherapy (or radiotherapy) yielded the highest sequential resection rate (30.6%) and 5-year survival (28.0%) as compared with double combination and single modality treatment. The 5-year survival of 33 patients receiving sequential resection after cytoreduction therapy was 63.2%. It is suggested that cytoreduction and sequential resection might offer a hope for surgically verified unresectable PLC.
17
Philip R. Exelby, Robert M. Filler, Jay L. Grosfeld · Journal of Pediatric Surgery · 1975 · 329 citations
Medicine, Oncology, Pediatrics +15
Clinical evaluation of cryosurgery in the treatment of primary liver cancer Report of 60 Cases
Xin-Da Zhou, Zhao–You Tang, Ye‐Qin Yu et al. · Cancer · 1988 · 174 citations
Surgery of small hepatocellular carcinoma. Analysis of 144 cases
Zhao–You Tang, Ye‐Qin Yu, Xin‐Da Zhou et al. · Cancer · 1989 · 132 citations